Charmaine Lykins, MBA
Chief Commercial Officer
Charmaine is Maplight’s Chief Commercial Officer. She leads the Company’s commercial strategic planning and execution.
She has over 25 years of psychiatry and neurology focused commercial experience gained from organizations recognized as leaders in CNS including Acadia, Eli Lilly, Lundbeck, and Sunovion. Prior to Maplight she was Chief Commercial Officer of Karuna Therapeutics where she built the commercial capabilities for the launch of KarXT in schizophrenia and Alzheimer’s disease psychosis. Her commercial experience includes commercial strategy and execution for 10 product launches in the US and globally for CNS indications. Top brands she has commercialized include ABILIFY MAINTENA®, CYMBALTA®, LATUDA®, NUPLAZID®, PROZAC®, REXULTI®, ZYPREXA®, among other first-in-class treatments for psychiatric and neurological conditions.
Ms. Lykins has an MBA with an emphasis in international business from the University of South Carolina. She also has bachelor’s degrees in chemistry and honors humanities from Ball State University.